Colorado veterinary diagnostics maker Heska is celebrating record first quarter earnings powered by a better-than-expected performance for its vaccines and pharma unit and strong sales for its blood tests. The results come as music to the company’s ears as it continues to deliver on a turnaround plan that it rolled out in 2014.